The evolving story of renal translocation carcinomas

American Journal of Clinical Pathology

Volumn 126, Issue 3, 2006, Pages 332-334

  Argani, Pedram ^a   Ladanyi, Marc ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CHROMOSOME TRANSLOCATION; DISEASE CLASSIFICATION; EDITORIAL; GENE FUSION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; RENAL TRANSLOCATION CARCINOMA;

EID: 33748338144     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/EAEJTJGD5J4J3B4F     Document Type: Editorial

References (16)

1. Eble JN, Sauter G, Epstein J, et al, ed. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC; 2004. World Health Organization Classification of Tumours.
2. Renshaw AA, Granter SR, Fletcher JA, et. al. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795-802.
3. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25:363-378.
4. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
5. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
6. Clark J, Lu Y-J, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239.
7. Ladanyi M, Lui MY, Antonescu CR et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57.
8. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761.
9. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096.
10. Davis IJ, His B-L, Arroyo JD, et al. Cloning of a novel Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q12) chromosome translocation. Proc Natl Acad Sci U S A. 2003;100:6051-6056.
11. Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12:1661-1669.
12. Argani P, Laé M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA-PCR. Am J Surg Pathol. 2005;29:230-240.
13. Ramphal R, Pappo A, Zielenska M, et. al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am J Clin Pathol. 2006;126:349-364.
14. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney following chemotherapy in childhood. J Clin Oncol. 2006;24:1529-1534.
15. Chang KL, Folpe AL. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol. 2001;8:273-275.
16. Meyer PN, Clark JL, Flanigan RC, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adult patients. Mod Pathol. 2006;19(suppl 1):50A. Abstract 692.